EUVIMEDEUVIMED entdecken
Crossref

Contrast-enhanced ultrasound (CEUS) – assessed tumor perfusion increases with malignancy in lipomatous tumors: a prospective pilot study

Paul Mick, Marie-Sophie Rohner, Tobias Renkawitz, Burkhard Lehner, Julian Doll

Ultraschall in der Medizin - European Journal of Ultrasound · 01.08.2023 · 44 (S 01 S 01) · S3-S4

DOI: 10.1055/s-0043-1772264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ultraschall in der Medizin - European Journal of Ultrasound, erschienen am 01.08.2023. Verfasst von Paul Mick und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Einleitung und Fragestellung Lipomatous soft-tissue tumors, which are the most common ones encountered in clinical practice, require a reliable assessment of the dignity of the tumour as it has a crucial impact on the further therapeutic procedure. Our aim in this study was to assess the preoperative tumor perfusion of malignant liposarcomas, semi-malignant atypical lipomatous tumors (ALT) and strictly benign lipomas as a surrogate parameter for malignancy, therefore focusing on the possible role of contrast-enhanced ultrasound (CEUS) in differentiating between those entities. Material und Methodik 12 patients with liposarcomas, 23 with ALT and 48 with lipomas were included in our prospective study and received a standardized, pre-operative ultrasound examination including CEUS. The perfusion was quantified via time-intensity curves and four representative perfusion parameters were selected: peak enhancement (PE), rise time (RT), wash-in perfusion index (WiPI) and wash-out rate (WoR). Ergebnisse Significant perfusion differences between the three different entities could be detected. Liposarcomas showed significantly higher perfusion levels than ALT (PE, p=0.01; WiPI, p=0.014; WoR, p=0.023). Focusing on patients with either ALT or liposarcomas, the sensitivity and specificity for detecting a liposarcoma were 72.7% and 78.3% with a cut-off peak enhancement of 326.1 arbitrary units (AUC=0.76). Regarding lipomas, perfusion parameters were significantly lower compared to ALT (PE, p=0.024; WiPI, p=0.031; WoR, p=0.017; RT, p=0.013). Zusammenfassung In this study, we compared liposarcomas, ALT and lipomas using a CEUS-based analysis of the tumor perfusion. We demonstrated significantly higher perfusion levels in liposarcomas compared to ALT, and higher perfusion in ALT than in lipoma. Publication History Article published online: 29 August 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Mick, P., Rohner, M., Renkawitz, T., Lehner, B., & Doll, J. (2023). Contrast-enhanced ultrasound (CEUS) – assessed tumor perfusion increases with malignancy in lipomatous tumors: a prospective pilot study. Ultraschall in der Medizin - European Journal of Ultrasound, 44(S 01 S 01), S3-S4. https://doi.org/10.1055/s-0043-1772264

Vancouver

Mick P, Rohner M, Renkawitz T, Lehner B, Doll J. Contrast-enhanced ultrasound (CEUS) – assessed tumor perfusion increases with malignancy in lipomatous tumors: a prospective pilot study. Ultraschall in der Medizin - European Journal of Ultrasound. 2023;44(S 01 S 01):S3-S4. doi:10.1055/s-0043-1772264

BibTeX
@article{Mick2023,
  author = {Mick, Paul and Rohner, Marie-Sophie and Renkawitz, Tobias and Lehner, Burkhard and Doll, Julian},
  title = {Contrast-enhanced ultrasound (CEUS) – assessed tumor perfusion increases with malignancy in lipomatous tumors: a prospective pilot study},
  journal = {Ultraschall in der Medizin - European Journal of Ultrasound},
  year = {2023},
  volume = {44},
  number = {S 01 S 01},
  pages = {S3--S4},
  doi = {10.1055/s-0043-1772264}
}
Kostenlos starten →